Oncolytic Virus to Be Studied in Advanced Lung Cancer
The oncolytic virus, MEM-288 will be studied in combination with Opdivo for patients with non-small cell lung cancer that progressed on standard therapy.
Source: curetoday.com
Andreas Saltos News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Andreas Saltos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Andreas Saltos Today - Breaking & Trending Today
Moffitt Initiates Groundbreaking Clinical Trial with Oncolytic Virus for Non-Small Cell Lung Cancer
Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer whose disease has progressed following in
Source: newswise.com
Moffitt Initiates Groundbreaking Clinical Trial with Oncolytic Virus for Non-Small Cell Lung Cancer
Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer whose disease has progressed following in
Source: newswise.com
Reflex Molecular Testing May Enhance Targeted Therapy Benefit in Early-Stage Lung Cancer
Jobelle Baldonado, MD, highlights the emergence of targeted therapies and the need for reflex-ordered molecular testing in early-stage lung cancer.
Source: onclive.com
Dr Saltos on Pembrolizumab Plus Vorinostat in mNSCLC
Andreas Saltos, MD, discusses final results from a phase 2 trial of first-line pembrolizumab plus vorinostat in patients with metastatic non–small cell lung cancer.
Source: onclive.com